These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4263743)

  • 1. Cerebrospinal fluid choline in extrapyramidal disorders.
    Aquilonius SM; Nyström B; Schuberth J; Sundwall A
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.
    Welch MJ; Markham CH; Jenden DJ
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):367-74. PubMed ID: 132512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders.
    Flentge F; Hajonides-van Der Meulen WM; Lakke JP; Teelken AW
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):207-9. PubMed ID: 6707661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
    Curzon G; Gumpert J; Sharpe D
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):514-9. PubMed ID: 4261957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
    Consolo S; Ladinsky H; Bianchi S; Caraceni T
    Arch Psychiatr Nervenkr (1970); 1977 May; 223(3):265-70. PubMed ID: 142461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
    Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H
    Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease.
    Gårseth M; Sonnewald U; White LR; Rød M; Zwart JA; Nygaard O; Aasly J
    J Neurosci Res; 2000 Jun; 60(6):779-82. PubMed ID: 10861790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
    Barkhatova VP; Kandel' EI; Demina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid choline levels are decreased in Parkinson's disease.
    Manyam BV; Giacobini E; Colliver JA
    Ann Neurol; 1990 Jun; 27(6):683-5. PubMed ID: 2360805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.
    McGeer PL; McGeer EG
    J Neurochem; 1976 Jan; 26(1):65-76. PubMed ID: 3629
    [No Abstract]   [Full Text] [Related]  

  • 15. CSF-protein patterns in extrapyramidal diseases. Preliminary report with special reference to the protein patterns in Huntington's chorea.
    Kjellin KG; Stibler H
    Eur Neurol; 1974; 12(3):186-94. PubMed ID: 4139015
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid choline levels in Parkinson's disease.
    Nasr A; Bertrand N; Giroud M; Septien L; Gras P; Dumas R; Beley A; Bralet J
    Ann Neurol; 1993 Jul; 34(1):114-5. PubMed ID: 8517672
    [No Abstract]   [Full Text] [Related]  

  • 17. CSF choline levels in neurologically disturbed children.
    Flentge F; Begeer JH; Mulder-Hajonides van der Meulen WR; Teelken AW
    Acta Neurol Scand; 1989 Feb; 79(2):160-5. PubMed ID: 2711823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.
    Prell GD; Green JP
    Agents Actions Suppl; 1991; 33():343-63. PubMed ID: 1828934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
    Lakke JP; Teelken AW
    Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
    Ferrarese C; Appollonio I; Frigo M; Meregalli S; Piolti R; Tamma F; Frattola L
    Neurology; 1990 Apr; 40(4):632-5. PubMed ID: 2138718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.